Clinical Trial Update: Phase II Study of Irinotecan/Capecitabine in Patients With Antracycline/Taxane Pretreated MBC [Phase 2]

View source ↗

Summary

Phase II study of irinotecan plus capecitabine in anthracycline/taxane-pretreated metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (Xeloda) (Capecitabine)
• Irinotecan (Camptosar) (Irinotecan)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Breast Cancer Metastatic | Phase 2 | Status: COMPLETED